AGR2 and neoplasm: ChIP-Seq and chromatin interaction analysis by paired-end tag sequencing (ChIA-Pet) studies defining global ER-binding sites further support the targeted binding and transcriptional activation of AGR2 by ER in cell lines and primary tumor tissue, and an increased number of occupied ER-binding sites may correlate with poor prognosis [14, 21–23].